Related Experiment Video

Updated: Jun 10, 2026

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits
06:46

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits

Published on: February 28, 2025

New technologies in the genetic approach to sudden cardiac death in the young

M Brion1, I Quintela, B Sobrino

  • 1Genomics Medicine Group, Galician Foundation of Genomic Medicine and University of Santiago de Compostela, CIBERER, Santiago de Compostela, Spain. maria.brion@usc.es

Forensic Science International
|August 14, 2010
PubMed

Insights

Sudden cardiac death (SCD) in young people is often caused by genetic heart disorders. This review details advanced technologies like next-generation sequencing for diagnosing these conditions.

Area of Science:

  • Cardiovascular Genetics
  • Forensic Pathology
  • Molecular Diagnostics

Background:

  • Sudden cardiac death (SCD) remains a significant challenge in forensic pathology, particularly when the cause of death is undetermined.
  • A notable proportion of unexplained SCD in young, healthy individuals is attributed to inherited cardiac conditions, including cardiomyopathies and arrhythmogenic disorders.

Purpose of the Study:

  • To provide a comprehensive overview of current technologies for investigating the genetic basis of sudden cardiac death.
  • To highlight advancements in genetic analysis relevant to forensic pathology and inherited cardiac conditions.

Main Methods:

  • Review of mutation screening approaches for identifying genetic variants.
  • Discussion of genome-wide association studies (GWAS) in understanding genetic predispositions.
  • Exploration of next-generation sequencing (NGS) technologies for comprehensive genetic analysis.

Main Results:

  • Various technological advancements are improving the ability to diagnose genetic heart disorders.
  • Next-generation sequencing offers a powerful tool for analyzing genetically heterogeneous disorders associated with SCD.

Conclusions:

  • Technological progress is enhancing the diagnosis of genetic causes of sudden cardiac death.
  • Advanced genetic analysis, particularly NGS, is crucial for resolving unexplained SCD in young individuals.

More Related Videos

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk05:15

Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk

Published on: July 27, 2022

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...